logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Matthew J. Matasar

Memorial Sloan Kettering Cancer Center

47H-index
444Paper Count
8.3KCitation Count
Published Papers 67
Publication Date
logo
Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma
errAmerican Journal of Hematology
IF9.9
err2026-03-17
err0
PREAI
errGeoffrey Shouse; Matthew Matasar; Lu Chen; Jennifer Crombie; Jonathon Cohen; Ranjana Advani; Ann LaCasce; Leslie Popplewell; Sandrine Puverel; Lacolle Peters; Shari Daniels; James Godfrey; Matthew Mei; Swetha Thiruvengadam; Lihua E. Budde; Liana Nikolaenko; Steven T. Rosen; Larry W. Kwak; Stephen J. Forman; Alex F. Herrera
errShare
errSave
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.
errBlood Advances
IF7.1
err2026-02-09
err0
errOAAI
errKatharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
errShare
errSave
Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC Consortium
errBlood Advances
IF7.1
err2025-11-10
err0
errOAAI
errJohn S. Wang; Brandon L. Ellsworth; Megan Melody; Narendranath Epperla; Deborah Stephens; Jason Romancik; Matthew Cortese; Rahul Bhansali; Tamara K. Moyo; Vaishalee Kenkre; Thomas Ollila; Brian Hess; Lindsey Fitzgerald; Geoffrey Shouse; Matthew Matasar; Megan M. Herr; James Davis; Christy Jesme; Ari R. Pelcovits; Jonathan Moreira
errShare
errSave
Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium
errBlood Advances
IF7.1
err2025-10-24
err0
errOAAI
errMegan Melody; Natalie Grover; Stephanie Franco; Jason Romancik; Matthew Cortese; Tamara K. Moyo; Rahul S. Bhansali; Thomas Ollila; Vaishalee Kenkre; Lindsey Fitzgerald; Brian Hess; Matt Matasar; Geoffrey Shouse; Kaitlin Annunzio; Megan M. Herr; James A. Davis; Christy Jesme; Ari Pelcovits; Jonathan Moreira; Shuo Ma; Jane N. Winter; Adam Lin; Alexey Danilov; Ishan Roy; Stefan K. Barta; Leo I Gordon; Deborah Stephens; Jonathon B. Cohen; Narendranath Epperla; Reem Karmali
errShare
errSave
Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCL
errBlood Advances
IF7.1
err2025-09-05
err0
errOAAI
errJon E. Arnason; Matthew Matasar; Stefano Luminari; David Tucker; Dylan Sun; Weiwei Tao; Yuan O. Zhu; Kunal Kundu; Namita T. Gupta; Allen Leary; Vladimir Jankovic; Srikanth Ambati; Hesham Mohamed; Aafia Chaudhry; Jurriaan Brouwer-Visser
errShare
errSave
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
errBlood Cancer Journal
IF11.6
err2025-08-29
err0
errOAAI
errGiulio Cassanello; Esther Drill; Annie Qiu; Mark D. Ewalt; Paul Hamlin; Steven M. Horwitz; Erel Joffe; Anita Kumar; Alison J. Moskowitz; Ariela Noy; Colette Owens; Maria Lia Palomba; Andrew D. Zelenetz; Ahmet Dogan; Klaus J. Busam; Joachim Yahalom; Gilles Salles; Matthew J. Matasar; Lorenzo Falchi
errShare
errSave
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
errBlood Advances
IF7.1
err2025-08-07
err0
errOAAI
errZachary D. Epstein-Peterson; Anath C. Lionel; Ashlee Joseph; Esther Drill; Suheil Albert Atallah-Yunes; Taylor R. Brooks; Elise A. Chong; Emeline R. Chong; Jamie Dela Cruz; Matthew J. Frank; Andrew Ip; Madiha Iqbal; Caron A. Jacobson; Manali K. Kamdar; Reem Karmali; Ofrat Beyar-Katz; Kami J. Maddocks; Matthew J. Matasar; Daniel McLoughlin; Reid W. Merryman
errShare
errSave
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trial
errBlood Advances
IF7.1
err2025-07-21
err0
errOAAI
errRaphael Steiner; Liana Nikolaenko; Ranjit Nair; Venkatraman Seshan; Swetha Kambhampati Thiruvengadam; Niloufer Khan; Jeremy S. Abramson; Steven Horwitz; Matthew Matasar; Colette Owens; Ildefonso Ismael Rodriguez Rivera; David J. Straus; Timothy S. Pardee; Sanjeev Luther; Sabrina Saboukoulou; Win Su Thet; Shreya Vemuri; Ariela Noy
errShare
errSave
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study
errBlood Cancer Journal
IF11.6
err2025-06-21
err0
errOAAI
errFrederique St-Pierre; Subodh Bhatta; Peter G. Doukas; Madeline Jenkin; Kaitlin Annunzio; Alexandra E. Rojek; Alyssa Gibson; Yun Kyoung Tiger; Brittany McCall; Khaled Alhamad; Alec Hansen; Juan P. Alderuccio; Olutobi Adewale; Keem Patel; Asaad Trabolsi; Izidore S. Lossos; Lindsey Fitzgerald; Thomas A. Ollila; Matthew J. Matasar; Justin Kline; Reem Karmali; Narendranath Epperla
errShare
errSave
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma
errBlood Advances
IF7.1
err2025-04-07
err0
errOAAI
errNiloufer Khan; Parastoo B. Dahi; Farhad Khimani; Andrei R. Shustov; Mazyar Shadman; Jia Ruan; Alison J. Moskowitz; Andrew D. Zelenetz; Ariela Noy; David J. Straus; Pamela Drullinsky; Audrey Hamilton; Anita Kumar; Craig S. Sauter; Gunjan L. Shah; Matthew J. Matasar; Esther Drill; Theresa Davey; Helen Hancock; Nivetha Ganesan; Natasha Galasso; Koen van Beisen; Sergio Giralt; Steven M. Horwitz
errShare
errSave
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
errBLOOD CANCER JOURNAL
IF11.6
err2025-02-20
err1
errOAAI
errKittai, Adam S.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise; Davids, Matthew S.; Danilov, Alexey V.; Ding, Wei; Dowling, Mark R.; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J.; Ho, Carrie; Hwang, Steven R.; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A.; Parry, Erin; Rabe, Kari G.; Raess, Philipp W.; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Scott, Hamish W.; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M.; Thompson, Meghan C.; Thompson, Philip A.; Wang, Yucai; Yano, Max; Woyach, Jennifer A.
errShare
errSave
Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGraham, Tisheeka; Ackbarali, Tariqa; Kumar, Anita; Matasar, Matthew
errShare
errSave
Evaluation of Baseline CAR-Hematotox Scores to Predict Increased Severe Infection Risk in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Odronextamab
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errMatasar, Matthew; Tucker, David; Kim, Tae Min; Luminari, Stefano; Cheng, Yuan; Li, Jingjin; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia
errShare
errSave
Evaluation of CAR-Hematotox Scoring As a Predictor of Infection Risk Following Treatment with Odronextamab (a CD20xCD3 Bispecific Antibody) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errMatasar, Matthew; Tucker, David; Kim, Tae Min; Luminari, Stefano; Cheng, Yuan; Li, Jingjin; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia
errShare
errSave
Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errEpstein-Peterson, Zachary D.; Lionel, Anath C.; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R.; Chong, Elise A.; Chong, Emeline R.; Dela Cruz, Jamie; Frank, Matthew J.; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A.; Kamdar, Manali K.; Karmali, Reem; Maddocks, Kami J.; Matasar, Matthew; Merryman, Reid W.; Munoz, Javier; Riedell, Peter A.; Ryan, Christine E.; Salles, Gilles; Sauter, Craig S.; Sawalha, Yazeed; Shouval, Roni; Shukla, Navika; Stanisic, Alexander, V; Therwhanger, Dylan; Van Besien, Herman; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D.; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita
errShare
errSave
Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBudde, Elizabeth; Matasar, Matthew; Sehn, Laurie H.; Assouline, Sarit E.; Kuruvilla, John; Flinn, Ian W.; Yoon, Sung-Soo; Bosch, Francesc; Greenwald, Daniel; Gutierrez, Norma C.; Tzachanis, Dimitrios; Marlton, Paula; Mcguirt, Delaney; Yin, Shen; Wei, Michael C.; Kwan, Antonia; Tracy, Samuel; Penuel, Elicia; Bartlett, Nancy L.
errShare
errSave
Clinical Outcomes of Transformed Follicular Lymphoma with CAR T-Cell Therapy: A US Multicenter Real-World Analysis
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCortese, Matthew J.; Herr, Megan M.; Nair, Nisha; Romancik, Jason; Grover, Natalie; Bhansali, Rahul S.; Thomas, Colin; Moyo, Tamara K.; Kenkre, Vaishalee P.; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Annunzio, Kaitlin; Davis, James A.; Jesme, Christy; Pelcovits, Ari; Melody, Megan; Moreira, Jonathan; Lin, Adam Yuh; Ma, Shuo; Winter, Jane N.; Niu, Alex; V. Danilov, Alexey; Shah, Nirav N.; Stephens, Deborah M.; Cohen, Jonathon B.; Gordon, Leo I.; Barta, Stefan K.; Epperla, Narendranath; Karmali, Reem
errShare
errSave
Hodgkin Lymphoma Transformation in Patients Who Received No Prior Chemotherapy for CLL/SLL: Outcomes from a Multicenter Retrospective Study in the Modern Era of Therapy
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errHampel, Paul J.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise A.; Danilov, Alexey; Davids, Matthew S.; Dvorak-Kornaus, Kaitlyn M.; Freedman, Hannah; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Parikh, Sameer A.; Parry, Erin M.; Rabe, Kari G.; Raess, Phil; Rai, Manoj; Rhodes, Joanna M.; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Shouse, Geoffrey; Spurgeon, Stephen E.; Stephens, Deborah M.; Wang, Yucai; Woyach, Jennifer A.; Yano, Max; Zulfa, Omer; Kittai, Adam S.
errShare
errSave
Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGraham, Tisheeka; Ackbarali, Tariqa; Kowalski, Katie; Castellino, Sharon M.; Roth, Lisa Giulino; Ehrhardt, Matthew J.; Matasar, Matthew
errShare
errSave
Lower Total Cost of Care with Mosunetuzumab Compared with Alternative Novel Treatment Options in Third-Line or Later Relapsed/Refractory Follicular Lymphoma: A United States Third-Party Payer Perspective
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errMatasar, Matthew; Rosettie, Katherine L.; Lin, Shih-Wen; Wu, Mei; Ma, Esprit
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
N
Nikolaus Schultz
H-index: 162 · Papers: 1.8K
P
Philippe Moreau
H-index: 159 · Papers: 2.3K
C
Christopher D.�M. Fletcher
H-index: 157 · Papers: 846
R
Ross L. Levine
H-index: 147 · Papers: 1.5K
D
David N. Louis
H-index: 136 · Papers: 635
View more